TAMPA, Fla. – Biotech startups using research to make advances in cancer treatment and patient care will be spotlighted at Moffitt Cancer Center’s tenth annual Business of Biotech Conference. The event, which brings together biomedical companies, startups, research organizations, entrepreneurs and investors, offers networking, collaboration and partnership opportunities. This year’s conference is March 18, 7:45 a.m. – 3 p.m., in Moffitt’s Vincent A. Stabile Research Building.
“Business of Biotech has grown to become a premier life science event in Florida, and it draws national attention to the local biotech cluster,” said Jarett Rieger, conference chairman and director of Moffitt’s Office of Technology Management and Commercialization. “This conference gives Moffitt researchers the opportunity to connect with investors and collaborators in their field, ultimately leading to the commercialization of their discoveries. A meeting between Moffitt researchers and Celgene at the conference a few years ago led to one of the most significant licensing agreements in Moffitt’s history. Partnerships like this help turn our research into treatments for patients more quickly.”
This year’s interview-style keynote address features Arie Belldegrun, M.D., F.A.C.S., CEO and founder of Kite Pharma with a distinguished tenure in the life sciences field and closely involved with the founding and advancement of successful biopharmaceutical companies. He will be interviewed on stage by Sam Donaldson, former ABC News correspondent and Moffitt Board of Advisors member, who will lead Belldegrun through a conversation about the exciting immunotherapy field for cancer treatment.
“We are thrilled to have Arie Belldegrun speak at our conference this year,” said Rieger. “Kite Pharma began as a startup and has come to the forefront of the immuno-oncology field under his leadership. He will give attendees great tips for growing their own businesses.”
In addition to Belldegrun’s appearance, the conference will include breakout sessions on fundraising trends, Immuno-Oncology, academic-industry partnerships and an investor forum.
There will also be tours of Moffitt Cancer Center’s cutting edge and high tech research facilities on the hospital’s Magnolia Campus.
Business of Biotech, is partially supported by the Hillsborough County Economic Development Innovation Initiative. It is free and open to the public, but seating is limited and reservations are required. To register, visit http://bit.ly/MoffittBOB2016.
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. One of the three largest cancer centers in the United States based on patient volume, the Tampa-based facility is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in Florida and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. Moffitt devotes more than 2 million square feet to research and patient care. With more than 5,000 team members, Moffitt has an economic impact in the state of $1.9 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.